---
figid: PMC6278600__nihms-993578-f0001
figtitle: Postulated cellular mechanisms of 20-HETE bioactions in the blood vessel
  wall
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Oryctolagus cuniculus
- Canis lupus familiaris
- Castor fiber
- Homo sapiens
- Candida dubliniensis
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Canis lupus familiaris
- Oryctolagus cuniculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6278600
filename: nihms-993578-f0001.jpg
figlink: /pmc/articles/PMC6278600/figure/F1/
number: F1
caption: Postulated cellular mechanisms of 20-HETE bioactions in the blood vessel
  wall. 20-HETE biosynthesis is stimulated by factors such as androgen, high fat,
  hypoxia/ischemia and vasoactive hormones. 20-HETE binds to its receptor GPR75 and
  in endothelial cells (EC), triggering a signaling cascade that is initiated by a
  Gαq/11− and GIT1-mediated c-Src activation and EGFR phosphorylation which is followed
  by activation of MAPK (ERK1/2) and IKKβ-NF-κB leading to ACE induction, eNOS uncoupling
  and production of inflammatory cytokines. In vascular smooth muscle cells (VSMC),
  the activation of Gαq/11− and GIT1 following 20-HETE binding to GPR75 leads to activation
  of PKC and c-Src, respectively, both kinases phosphorylate the BK channel, inhibiting
  the BK channel which further sensitize the contractile apparatus. It is also postulated
  that the Gαq/11 activation leads to increase intracellular Ca2+ via PLC-IP3 pathway
  which further contribute to 20-HETE vasoconstrictor activity. PKC activation following
  binding of 20-HETE to GPR75 may also be a key to 20-HETE ability to stimulate VSMC
  migration and proliferation ().
papertitle: 20-HETE in the regulation of vascular and cardiac function.
reftext: Petra Rocic, et al. Pharmacol Ther. 2018 Dec;192:74-87.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9393162
figid_alias: PMC6278600__F1
figtype: Figure
redirect_from: /figures/PMC6278600__F1
ndex: 88b21a68-dee2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6278600__nihms-993578-f0001.html
  '@type': Dataset
  description: Postulated cellular mechanisms of 20-HETE bioactions in the blood vessel
    wall. 20-HETE biosynthesis is stimulated by factors such as androgen, high fat,
    hypoxia/ischemia and vasoactive hormones. 20-HETE binds to its receptor GPR75
    and in endothelial cells (EC), triggering a signaling cascade that is initiated
    by a Gαq/11− and GIT1-mediated c-Src activation and EGFR phosphorylation which
    is followed by activation of MAPK (ERK1/2) and IKKβ-NF-κB leading to ACE induction,
    eNOS uncoupling and production of inflammatory cytokines. In vascular smooth muscle
    cells (VSMC), the activation of Gαq/11− and GIT1 following 20-HETE binding to
    GPR75 leads to activation of PKC and c-Src, respectively, both kinases phosphorylate
    the BK channel, inhibiting the BK channel which further sensitize the contractile
    apparatus. It is also postulated that the Gαq/11 activation leads to increase
    intracellular Ca2+ via PLC-IP3 pathway which further contribute to 20-HETE vasoconstrictor
    activity. PKC activation following binding of 20-HETE to GPR75 may also be a key
    to 20-HETE ability to stimulate VSMC migration and proliferation ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd36
  - Cpe
  - Gpr75
  - Egfr
  - Git1
  - Stoml3
  - Src
  - Tgfb1i1
  - Apk
  - Hspg2
  - Pik3r1
  - Rhoa
  - Akt1
  - Ace
  - Il6
  - Eif4e
  - Nos3
  - Fat1
  - RGD1565355
  - Prkcg
  - Pik3cg
  - FAT1
  - GPR75
  - EGFR
  - GIT1
  - SRC
  - PIK3CB
  - RHOA
  - AKT1
  - ACE
  - IL6
  - EIF4E
  - NOS3
  - CD36
  - STOML3
  - TGFB1I1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ROCK1
  - ROCK2
  - AKT2
  - AKT3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - EIF4E2
  - EIF4E3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ENO4
  - ft
  - kug
  - faf
  - ec
  - ca
  - bk
  - sro
  - Src64B
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Nplp1
  - norpA
  - sl
  - Plc21C
  - IKKepsilon
  - key
  - IKKbeta
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Rho1
  - Rok
  - Akt
  - Thor
  - Acer
  - Ance
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - cv-d
  - MKP-4
  - p38b
  - rl
  - Androgen
  - Ca
  - PIP
  - Ischemia/Hypoxia
  - Nypertrophy T  Vascular Dysfunction
  - Hypertension
---
